Delay by patients and doctors in treatment of Pancoast tumor
Elimination of pancoast tumor by carboplatin, paclitaxel, and concurrent radiation
Preoperative chemoradiotherapy with carboplatin (AUC 1.5), paclitaxel (40 mg/m2), and concurrent extracorporeal radiation (40 Gy) was used to treat a Pancoast tumor (clinical T3N0M0), without causing adverse events.
Induction chemoradiotherapy followed by surgery is considered to be a standard treatment strategy for Pancoast tumor according to the results of ours.
Patients are not eligible with the presence of a Pancoast tumor, involvement of N2/N3 lymph nodes and/or distant metastases.